The Billion‑Dollar Bet and the CrossBridge Exit: Texas’ April “AI‑Native” Inflection Point
May 2026 | Vol. 1, Issue 1
Mapping the intersection of medicine and venture capital across the Texas Triangle.
EXECUTIVE SUMMARY: THE "AI-NATIVE" INFLECTION
April 2026 was the month the "Texas Triangle" (Austin-Houston-Dallas) officially pivoted from health-tech adoption to AI-native infrastructure. Between the historic $1 billion total commitment from the Dells to UT Austin and Eli Lilly’s $300M acquisition of Houston’s CrossBridge Bio, the signal is clear: Texas is no longer just a "back-office" hub for healthcare—it is a primary engine for clinical breakthroughs and liquidity.
Macro Signals: Exits, Federal Funding & Infrastructure
Major Exit: Lilly Acquires CrossBridge Bio ($300M)
Federal Momentum: ARPA‑H EVIDENT Initiative ($139M)
Houston teams Motif Neurotech and INVI MindHealth were selected as performer teams in ARPA‑H’s $139M behavioral health initiative. Why it matters: Federal agencies are signaling that objective measurement—neuromodulation, computational psychiatry, and precision psychedelics—is the next frontier. Texas is leading this shift.
Infrastructure: The $1B Dell “AI‑Native” Hospital
The Michael & Susan Dell Foundation’s $750M gift pushed their total UT Austin commitment past $1B. Why it matters: UT Dell Medical Center is positioning itself as the first AI‑native hospital system, creating a regulatory‑grade sandbox for startups in workflow automation, predictive diagnostics, and clinical AI.
APRIL 2026: THE DEAL TRACKER
| Company | Hub | Stage | Deal Value | Lead / Notable News |
|---|---|---|---|---|
| CrossBridge Bio | Houston | EXIT | $300.0M | Acquired by Eli Lilly (April 14) |
| UT Dell Medical | Austin | Grant | $750.0M | Final gift of the $1B Dell commitment |
| Motif Neurotech | Houston | ARPA-H | Part of $139M | EVIDENT Initiative awardee |
| INVI MindHealth | Denver/Houston | ARPA-H | Part of $139M | EVIDENT Initiative awardee ; HQ in Denver, testing in Houston |
| UT San Antonio | SA | Federal | $38.0M | Barshop Institute longevity study |
Context: Deal flow this month skewed toward infrastructure and federal science, not traditional venture rounds. That’s a tell: Texas is building the substrate—clinical, computational, and regulatory—on which the next decade of venture-scale companies will run.
Early‑Stage Deal Flow: Seed → Series B (Texas‑Wide)
Seed Rounds
Galatiq (Austin) – $3M Seed AI‑driven marketing automation with applicability to patient engagement and health‑system operations.
Surf Therapeutics (Austin) – $6M Seed Respiratory biotech platform with strong translational potential; backed by SOSV and Elderberry.
Bild (Austin) – $1M Seed Workflow automation for technical teams; early traction in regulated industries.
Neuraware (Austin) – TxHC Winner, building a DARPA‑funded wearable focused‑ultrasound‑EEG platform for non‑invasive deep‑brain neuromodulation, initially targeting drug‑resistant epilepsy and a “Sleep Switch” for sleep–wake state modulation.
GenrAB (Dallas) – Pre‑Seed/Seed Protein‑engineering platform for neurodegeneration; emerging from UTSW’s structural biology group.
San Antonio Longevity Team (SA) – Seed‑Stage Federal‑Backed Aging‑biology platform aligned with the Barshop Institute’s $38M federal award.
Series A Rounds
Scalvy (Austin) – $14M Series A Power electronics infrastructure with relevance to hospital energy resilience and clinical uptime.
Series B Rounds
Striveworks (Austin) – $18M Series B AI governance and deployment platform increasingly used by health systems and payers.
THE DEEP DIVE
LILLY & THE DUAL-PAYLOAD BOOM
The most significant exit this month was Eli Lilly’s acquisition of Houston-based CrossBridge Bio for up to $300 million.
The Tech: CrossBridge is a pioneer in "dual-payload" antibody-drug conjugates (ADCs)—cancer treatments that fire two toxic "warheads" at a tumor instead of one.
The Take: This is a huge win for the TMC Venture Fund, which backed the company early. It proves that Texas-grown biotech, rooted in local academic research (UT Health Science Center at Houston), can reach exit velocity without moving to Boston or SF.
The acquisition also puts Houston squarely on the map for next‑generation ADC innovation—expect follow‑on capital to chase similar dual‑payload or modular conjugation platforms.
THE $1B DELL "AI-NATIVE" HOSPITAL
On April 21, the Michael & Susan Dell Foundation announced a $750M gift, bringing their total UT Austin support past the $1 billion mark.
The Future: This funding will build the UT Dell Medical Center, described as the first "AI-native" hospital system.
The Opportunity: For VCs, this creates a massive testbed. Startups focusing on clinical workflow automation and predictive diagnostics will have a world-class playground to validate their tech right here in Austin.
FEDERAL MOMENTUM: ARPA-H TEAMS IN HOUSTON
The federal government is doubling down on Texas through the ARPA-H EVIDENT Initiative. This month, $139 million was awarded to behavioral health research teams.
The Texas Winners: Houston-based Motif Neurotech and INVI MindHealth were selected as performer teams.
The Thesis: Federal agencies are signaling that "objective measurement" for mental health (neuromodulation and psychedelics) is the next frontier. Texas is leading the pack in this "hard-science" approach to behavioral health.
TEXAS HEALTH CATALYST: THE BRAIN HEALTH COHORT
The Texas Health Catalyst (TxHC) held its Spring "Roundup & Rodeo" on April 30 at Capital Factory.
Focus: This spring’s cohort was strictly focused on Dementia, Neurodegeneration, and Brain Health.
One to Watch: Keep an eye on Neuraware, a team building a DARPA‑funded wearable focused‑ultrasound‑EEG platform for non‑invasive deep‑brain neuromodulation, initially targeting drug‑resistant epilepsy and a “Sleep Switch” for sleep–wake state modulation.
UPCOMING EVENTS: MAY 2026
If you are looking to network with the firms mentioned in this report, mark your calendars for:
Health Supernova (Austin, May 13–14) The flagship Texas health‑tech event. Expect ARPA‑H, CPRIT, and multiple coastal funds scouting Texas deal flow. (Registration)
BIO BREAK (Fort Worth, May 19) A dense networking environment for North Texas life sciences—particularly strong for BD and pharma‑services operators. (Registration)
Texas Venture Gala (Austin, May 26-27) statewide gathering that brings together investors, founders, policymakers, and innovation leaders for a full day of briefings, networking, and an evening awards celebration recognizing leadership across Texas’s venture and startup ecosystem. (Registration)
Eli Lilly/CrossBridgeTexas Medical Center. "Texas Medical Center Venture Fund Announces Acquisition of Crossbridge Bio for $300 Million by Eli Lilly." Texas Medical Center, 14 Apr. 2026. www.tmc.edu/press-releases/texas-medical-center-venture-fund-announces-acquisition-of-crossbridge-bio-for-300-million-by-eli-lilly/. "A Turning Point for ADCs." Nature, Nov. 2024. Advertisement feature. CrossBridge Bio. crossbridgebio.com/wp-content/uploads/2024/11/d43747-024-00100-z.pdf.Dell"Dell Foundation Gift to UT Austin Aims to Transform Healthcare with AI." Austin American-Statesman, 2026, www.statesman.com/news/healthcare/article/dell-gift-ut-austin-medical-center-ai-22212520.php."Dell Foundation Pledges $750 Million to Help Build UT Austin Medical Center." AP News, Apr. 2026, apnews.com/article/michael-dell-susan-university-of-texas-healthcare-c58928b61803f0615ec15692548446c1.ARPA-HAdvanced Research Projects Agency for Health (ARPA-H). U.S. Department of Health and Human Services, 2026, arpa-h.gov/."ARPA-H Announces First Research Teams for $139 Million Initiative to Transform Behavioral Health and Bring New, More Precise and Effective Treatments to Americans." ARPA-H, 21 Apr. 2026, arpa-h.gov/news-and-events/arpa-h-announces-first-research-teams-139-million-initiative-transform-behavioral.GalatiqTracxn. “Galatiq – Company Profile, Funding, and Investors.” Tracxn, 2026, https://tracxn.com/d/companies/galatiq/__gjw5SIzKU7TIg2JAlbZvt5Qbj5ZfHjblfY1VG195XQM#about-the-company.Surf Ther."Surf Therapeutics Reports Positive First-in-Human Data and Secures Additional Financing, Bringing Total Funding to $6M as Rheumatoid Arthritis Clinical Study Begins." Business Wire, 17 Mar. 2026, www.businesswire.com/news/home/20260317016879/en/Surf-Therapeutics-Reports-Positive-First-in-Human-Data-and-Secures-Additional-Financing-Bringing-Total-Funding-to-%246M-as-Rheumatoid-Arthritis-Clinical-Study-Begins.Bild AIBild AI. "We are excited to share that Bild AI has joined Eli Lilly and Company!" LinkedIn, 2026, www.linkedin.com/posts/we-are-excited-to-share-that-bild-ai-has-share-7346612014770700289-P6Ys.NeurawareNeurawear. "Neurawear." LinkedIn, www.linkedin.com/company/neurawear/. Accessed 21 May 2026. DMS-OIE. "That's a wrap on another incredible Texas activity!" LinkedIn, 2026, www.linkedin.com/posts/dms-oie_thats-a-wrap-on-another-incredible-texas-activity-7456107464543907841-EaVT.GenrABPreston, Quincy. "UT Southwestern Spinout Emerges From Stealth With $5.6M to Push 'First in Class' Neuroprotective Therapy Into the Clinic." Dallas Innovates, 24 Apr. 2025, dallasinnovates.com/ut-southwestern-spinout-emerges-from-stealth-with-5-6m-to-push-first-in-class-neuroprotective-therapy-into-the-clinic/.UTSALee, Steven. "UT San Antonio's Barshop Institute to Receive up to $38M From ARPA-H." UT San Antonio Today, 27 Feb. 2026, news.utsa.edu/2026/02/ut-san-antonios-barshop-institute-to-receive-up-to-38-million-from-arpa-h/.ScalvyScalvy. "Scalvy Raises $13.9M Series A to Solve the Power Delivery Bottleneck for AI Data Centers, Grid, and Mobility." PR Newswire, 26 Mar. 2026, www.prnewswire.com/news-releases/scalvy-raises-13-9m-series-a-to-solve-the-power-delivery-bottleneck-for-ai-data-centers-grid-and-mobility-302725233.html.StriveworksStriveworks. "Striveworks Secures Growth Capital to Expand AI Operations Work in U.S. and Allied Defense Communities." PR Newswire, 23 Mar. 2026, www.prnewswire.com/news-releases/striveworks-secures-growth-capital-to-expand-ai-operations-work-in-us-and-allied-defense-communities-302722613.html."Striveworks Raises $18.0M Series B Funding." Signalbase, 30 Mar. 2026, www.trysignalbase.com/news/funding/striveworks-raises-180m-series-b-funding.Disclaimer: This report is for informational purposes only and does not constitute investment advice. The Givens Health Venture Report is independent and not affiliated with any of the firms or institutions mentioned.
